 |
|
|
| |
In Vivo Study of a LNP siRNA Investigational Agent Applied Sequentially with Immunomodulatory Treatments for Chronic Hepatitis B Infection
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting®
2017, October 20-24, 2017, Washington, DC
Emily P. Thi1, Hui Huang1, Luying Pei1, Xin Ye1, Chris Pasetka1, Angela Miller1, Alice H.L. Li1, Agnes Jarosz1, Sara Majeski1, Jang-June Park1, Chris Moore1, Rene Rijnbrand1, Amy C.H. Lee1, Michael J. Sofia1
1 Arbutus Biopharma Corp, Burnaby, BC, Canada & Warminster, PA, United States
|
| |
|
|
|
|
|
